Duska LR - Search Results

1

Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology.

Duska LR, Flynn CF, Chen A, Whall-Strojwas D, Goodman A. Duska LR, et al. Obstet Gynecol. 1998 Feb;91(2):278-82. doi: 10.1016/s0029-7844(97)00659-5. Obstet Gynecol. 1998. PMID: 9469289

2

Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer who are microsatellite instability (MSI)-high or are mismatch repair deficient (dMMR) in the United States.

Kelkar SS, Prabhu VS, Corman S, Odak S, Rusibamayila N, Macahilig C, Orlowski R, Duska L. Kelkar SS, et al. Gynecol Oncol. 2023 Feb;169:154-163. doi: 10.1016/j.ygyno.2022.10.016. Epub 2022 Nov 4. Gynecol Oncol. 2023. PMID: 36344294 Free article.

3

A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer.

Oaknin A, Gilbert L, Tinker AV, Brown J, Mathews C, Press J, Sabatier R, O'Malley DM, Samouelian V, Boni V, Duska L, Ghamande S, Ghatage P, Kristeleit R, Leath C 3rd, Dong Y, Veneris J, Pothuri B. Oaknin A, et al. Future Oncol. 2023 Aug;19(25):1709-1714. doi: 10.2217/fon-2022-1157. Epub 2023 Jun 29. Future Oncol. 2023. PMID: 37381977 Review.

4

Fertility options for patients with stages IA2 and IB cervical cancer: presentation of two cases and discussion of technical and ethical issues.

Duska LR, Toth TL, Goodman A. Duska LR, et al. Obstet Gynecol. 1998 Oct;92(4 Pt 2):656-8. doi: 10.1016/s0029-7844(98)00290-7. Obstet Gynecol. 1998. PMID: 9764652 Review.

5

Masculinizing sclerosing stromal cell tumor in pregnancy: report of a case and review of the literature.

Duska LR, Flynn C, Goodman A. Duska LR, et al. Eur J Gynaecol Oncol. 1998;19(5):441-3. Eur J Gynaecol Oncol. 1998. PMID: 9863907 Review.

6

Predictors of recurrence in surgical stage II endometrial adenocarcinoma.

Feltmate CM, Duska LR, Chang Y, Flynn CE, Nikrui N, Kiggundu E, Goodman A, Fuller AF, McIntyre JF. Feltmate CM, et al. Among authors: duska lr. Gynecol Oncol. 1999 Jun;73(3):407-11. doi: 10.1006/gyno.1999.5380. Gynecol Oncol. 1999. PMID: 10366468

7

Epithelial ovarian carcinoma in the reproductive age group.

Duska LR, Chang YC, Flynn CE, Chen AH, Goodman A, Fuller AF, Nikrui N. Duska LR, et al. Cancer. 1999 Jun 15;85(12):2623-9. doi: 10.1002/(sici)1097-0142(19990615)85:12<2623::aid-cncr19>3.0.co;2-o. Cancer. 1999. PMID: 10375111

8

A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.

Duska LR, Penson R, Supko JG, Finkelstein DM, Makastorsis T, Gallagher J, Borden K, Goodman A, Fuller AF, Nikrui N, Seiden MV. Duska LR, et al. Clin Cancer Res. 1999 Jun;5(6):1299-305. Clin Cancer Res. 1999. PMID: 10389912 Clinical Trial.

9

Clinically significant venous thromboembolism after gynecologic surgery.

Schorge JO, Goldhaber SZ, Duska LR, Goodman A, Feldman S. Schorge JO, et al. Among authors: duska lr. J Reprod Med. 1999 Aug;44(8):669-73. J Reprod Med. 1999. PMID: 10483535

10

Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer.

Cook S, Penson R, Duska L, Nikrui N, Goodman A, Fuller A, Seiden M. Cook S, et al. Gynecol Oncol. 2000 Apr;77(1):48-54. doi: 10.1006/gyno.1999.5710. Gynecol Oncol. 2000. PMID: 10739690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters